Article Details
Retrieved on: 2022-12-10 15:54:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Goldman Sachs upgraded shares of Jazz Pharmaceuticals ... Because of those updates, Goldman dropped its price target to $116 from $121, ...
Article found on: www.cnbc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here